These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23396730)

  • 1. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
    Ladero JM; Torrejón MJ; Sánchez-Pobre P; Suárez A; Cuenca F; de la Orden V; Devesa MJ; Rodrigo M; Estrada V; López-Alonso G; Agúndez JA
    Ann Hepatol; 2013; 12(2):199-204. PubMed ID: 23396730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.
    Petta S; Ferraro D; Cammà C; Cabibi D; Di Cristina A; Di Marco V; Di Stefano R; Grimaudo S; Mazzola A; Levrero M; Scazzone C; Craxì A
    Antivir Ther; 2012; 17(5):823-31. PubMed ID: 22505587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
    Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
    Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C.
    Azevedo LA; Matte U; Silveira TR; Bonfanti JW; Bruch JP; Álvares-da-Silva MR
    Ann Hepatol; 2017; 16(5):742-748. PubMed ID: 28809744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
    Terrier B; Carrat F; Geri G; Pol S; Piroth L; Halfon P; Poynard T; Souberbielle JC; Cacoub P
    J Hepatol; 2011 Oct; 55(4):756-61. PubMed ID: 21334402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
    Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P
    World J Gastroenterol; 2015 May; 21(18):5647-53. PubMed ID: 25987791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?
    Jin CN; Chen JD; Sheng JF
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):741-746. PubMed ID: 29664746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
    Bitetto D; Fattovich G; Fabris C; Ceriani E; Falleti E; Fornasiere E; Pasino M; Ieluzzi D; Cussigh A; Cmet S; Pirisi M; Toniutto P
    Hepatology; 2011 Apr; 53(4):1118-26. PubMed ID: 21480318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
    Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
    AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
    Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status and viral response to therapy in hepatitis C infected children.
    Eltayeb AA; Abdou MA; Abdel-aal AM; Othman MH
    World J Gastroenterol; 2015 Jan; 21(4):1284-91. PubMed ID: 25632203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
    Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
    Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
    Lange CM; Bojunga J; Ramos-Lopez E; von Wagner M; Hassler A; Vermehren J; Herrmann E; Badenhoop K; Zeuzem S; Sarrazin C
    J Hepatol; 2011 May; 54(5):887-93. PubMed ID: 21145801
    [TBL] [Abstract][Full Text] [Related]  

  • 15.  The relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis C.
    Mateos-Muñoz B; Devesa-Medina MJ; Matía-Martín MP; Torrejón MJ; Suárez A; Larrad-Sáinz A; Rey-Díaz-Rubio E; Cárdenas MC; Ortega-Medina L; Ladero JM
    Ann Hepatol; 2016; 15(4):492-500. PubMed ID: 27236148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy.
    Bitetto D; Bortolotti N; Falleti E; Vescovo S; Fabris C; Fattovich G; Cussigh A; Cmet S; Fornasiere E; Ceriani E; Pirisi M; Toniutto P
    Hepatology; 2013 Mar; 57(3):925-33. PubMed ID: 23213086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C.
    Atsukawa M; Tsubota A; Shimada N; Abe H; Kondo C; Itokawa N; Nakagawa A; Iwakiri K; Kawamoto C; Aizawa Y; Sakamoto C
    Dig Liver Dis; 2014 Aug; 46(8):738-43. PubMed ID: 24880716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.
    Ladero JM; Martin EG; Fernández C; Carballo M; Devesa MJ; Martínez C; Suárez A; Díaz-Rubio M; Agúndez JA
    J Gastroenterol Hepatol; 2012 Feb; 27(2):279-85. PubMed ID: 21722179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
    Petta S; Cammà C; Scazzone C; Tripodo C; Di Marco V; Bono A; Cabibi D; Licata G; Porcasi R; Marchesini G; Craxí A
    Hepatology; 2010 Apr; 51(4):1158-67. PubMed ID: 20162613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.